Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

Clinical trial NCT05176145 · UNKNOWN

Trial details

NCT number: NCT05176145
Sponsor: Vitadx
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-muscle Invasive Bladder Cancer (NMIBC)

Start date: 2022-04-05
Primary completion: 2025-02-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.